Interaction of sertraline and nimodipine on some behavioural tests in rats

Advances in Clinical and Experimental Medicine

Volumn 23, Issue 2, 2014, Pages 169-175

  Kaygisiz, Bilgin ^a   Ozatik, Fikriye Yasemin ^a   Erol, Kevser ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Elevated plus maze test; Forced swimming test; Nimodipine; Sertraline

Indexed keywords

CALCIUM CHANNEL; NIMODIPINE; SERTRALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ANXIETY DISORDER; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DEPRESSION; ELEVATED PLUS MAZE TEST; FEMALE; FORCED SWIM TEST; IMMOBILITY; MONOTHERAPY; NONHUMAN; RAT; REPEATED DRUG DOSE; SEROTONINERGIC SYSTEM; SINGLE DRUG DOSE; ANXIETY; DIVING; EXPERIMENTAL BEHAVIORAL TEST;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; CALCIUM CHANNEL BLOCKERS; DRUG INTERACTIONS; FEMALE; MAZE LEARNING; NIMODIPINE; RATS; RATS, WISTAR; SERTRALINE; SWIMMING;

EID: 84902166954     PISSN: 18995276     EISSN: None     Source Type: Journal    
DOI: 10.17219/acem/37043     Document Type: Article

References (30)

1. Li H, Foss SM, Dobryy YL, Park CK, Hires SA, Shaner NC, Tsien RY, Osborne LC, Voglmaier SM: Concurrent imaging of synaptic vesicle recycling and calcium dynamics. Front Mol Neurosci 2011, 4, 34.
2. 2+ channels alters transmitter release and short term plasticity. Neuroscience 2011, 192, 219-230.
3. Scott VE, Vortherms TA, Niforatos W, Swensen AM, Neelands T, Milicic IBanfor PN, King A, Zhong C, Simler G, Zhan C, Bratcher N, Boyce-Rustay JM, Zhu CZ, Bhatia P, Doherty G, Mack H, Stewart AO, Jarvis MF: A-1048400 is a novel, orally active, state-dependent neuronal calcium channel blocker that produces dose-dependent antinociception without altering hemodynamic function in rats. Biochem Pharmacol 2012, 83, 406-418.
4. Urbano FJ, Rosato-Siri MD, Uchitel OD: Calcium channels involved in neurotransmitter release at adult, neonatal and P/Q-type deficient neuromuscular junctions (Review). Mol Membr Biol 2002, 19, 293-300. (Pubitemid 36090790)
5. Galeotti N, Bartolini A, Ghelardini C: Blockade of intracellular calcium release induces an antidepressant-like effect in the mouse forced swimming test. Neuropharmacology 2006, 50, 309-316. (Pubitemid 43184359)
6. Busquet P, Nguyen NK, Schmid E, Tanimoto N, Seeliger MW, Ben-Yosef T, Mizuno F, Akopian A, Striessnig J, Singewald N: CaV1.3 L-type Ca2+ channels modulate depression-like behaviour in mice independent of deaf phenotype. Int J Neuropsychopharmacol 2010, 13, 499-513.
7. El Ganouni S, Tazi A, Hakkou F: Potential serotonergic interactions with the anxiolytic-like effects of calcium channel antagonists. Pharmacol Biochem Behav 1998, 60, 365-369. (Pubitemid 28282676)
8. Srivastava SK, Nath C: The differential effects of calcium channel blockers in the behavioural despair test in mice. Pharmacol Res 2000, 42, 293-297.
9. Nowak G, Paul IA, Popik P, Young A, Skolnick P: Ca2+ antagonists effect an antidepressant-like adaptation of the NMDA receptor complex. Eur J Pharmacol 1993, 247, 101-102. (Pubitemid 23281240)
10. Gaggi R, Dall'olio R: Actions of nimodipine on the serotonergic systems of rat brain. Gen Pharmac 1997, 29, 415-419. (Pubitemid 27412466)
11. Biala G, Budzynska B: Effects of acute and chronic nicotine on elevated plus maze in mice: involvement of calcium channels. Life Sci 2006, 79, 81-88.
12. Shinnick-Gallagher P, McKernan MG, Xie J, Zinebi F: L-type voltage-gated calcium channels are involved in the in vivo and in vitro expression of fear conditioning. Ann N Y Acad Sci 2003, 985, 135-149. (Pubitemid 36521112)
13. Nakazawa K, Inoue K, Ohara-lmaizumi M, Fujimori K, Takanaka A: Inhibition of Ca-channels by diazepam compared with that by nicardipine in pheochromocytoma PC12 cells. Brain Res 1991, 553, 44-50.
14. Deák F, Lasztóczi B, Pacher P, Petheö GL, Valéria Kecskeméti, Spät A: Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells. Neuropharmacology 2000, 39, 1029-1036. (Pubitemid 30155710)
15. Paul IA: Antidepressant activity and calcium signaling cascades. Hum Psychopharmacol 2001, 16, 71-80.
16. Pellow S, Chopin P, File SE, Briley M: Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985, 14, 149-167. (Pubitemid 16239568)
17. Porsolt RD, Anton G, Blavet N, Jalfre M: Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 1978, 47, 379-391.
18. 2+ channel signaling complexes in neurons. J Neurochem 2008, 105, 573-583.
19. Green AR, DeSouza RJ, Davies EM, Cross AJ: The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice. Br J Pharmacol 1990, 99, 41-46. (Pubitemid 20033783)
20. Czyrak A, Mogilnicka E, Maj J: Dihydropyridine calcium channel antagonists as antidepressant drugs in mice and rats. Neuropharmacology 1989, 28, 229-233. (Pubitemid 19078883)
21. Aburawi S, Al-Tubuly R, Alghzewi E, Gorash Z: Effects of calcium channel blockers on antidepressant action of Alprazolam and Imipramine. Libyan J Med 2007, 2, 169-175.
22. Czyrak A, Mogilnicka E, Siwanowicz J, Maj J: Some behavioral effects of repeated administration of calcium channel antagonists. Pharmacol Biochem Behav 1990, 35, 557-560. (Pubitemid 20115739)
23. Tazi A, Farh M, Hakkou F: Behavioral effects of a calcium channel antagonist: nifedipine. Fundam Clin Pharmacol 1991, 5, 229-236.
24. Biała G: Antidepressant-like properties of some serotonin receptor ligands and calcium channel antagonists measured with the forced swimming test in mice. Pol J Pharmacol 1998, 50, 117-124.
25. Cohen C, Perrault G, Sanger DJ: Assessment of the antidepressant-like effects of L-type voltage-dependent channel modulators. Behav Pharmacol 1997, 8, 629-638. (Pubitemid 27504711)
26. Bagdy G, Graf M, Anheuer ZE, Modos EA, Kantor S: Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. Int J Neuropsychopharmacol 2001, 4, 399-408. (Pubitemid 33151684)
27. To CT, Bagdy G: Anxiogenic effect of central CCK administration is attenuated by chronic fluoxetine or ipsapirone treatment. Neuropharmacology 1999, 38, 279-282. (Pubitemid 29073548)
28. ++ channel antagonists with Vogel-type conflict test in rats. Eur J Pharmacol 1994, 264, 107-110.
29. Viveros MP, Martín S, Ormazabal MJ, Alfaro MJ, Martín MI: Effects of nimodipine and nifedipine upon behavior and regional brain monoamines in the rat. Psychopharmacology (Berl) 1996, 127, 123-132. (Pubitemid 26298010)
30. Urani A, Romieu P, Portales-Casamar E, Roman FJ, Maurice T: The antidepressant-like effect induced by the sigma(1) (sigma(1)) receptor agonist igmesine involves modulation of intracellular calcium mobilization. Psychopharmacology (Berl) 2002, 163, 26-35. (Pubitemid 34985309)